Radical Meditech Private Limited
About Radical Meditech Private Limited
Data last updated:
Radical Meditech Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 April 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2022PTC396858.
The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹12 Lakh. It is led by directors Ratika Verma and Ankit Chhabra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mpl No – 1596 – Pvt No – 3 F/F B/S A C New Building Diwan Hall Chandni Chowk, Delhi, India – 110006.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.76 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.15 Lakh (net margin 0.2%) and EBITDA of ₹2.58 Lakh (EBITDA margin 0.5%).
Company details
Contact details
Radical Meditech Private Limited's registered office is in Delhi, Delhi.
- Registered AddressMpl No – 1596 – Pvt No – 3 F/F B/S A C New Building Diwan Hall Chandni Chowk, Delhi, India – 110006
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Radical Meditech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Radical Meditech Private Limited, buy the company report.
Financials of Radical Meditech Private Limited
FY 2025 filings availableRadical Meditech Private Limited reported revenue of ₹4.76 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 6% in the latest year. EBITDA fell 16% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2.58 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.15 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.5% | ||
| Net Profit Margin | 0.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Radical Meditech Private Limited, buy the company report.
Board of directors of Radical Meditech Private Limited
Radical Meditech has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ratika Verma | Director | 19 Apr 2022 | 4 Years 6 Months | Current |
| Ankit Chhabra | Director | 19 Apr 2022 | 4 Years 6 Months | Current |
Peer comparison
Radical Meditech Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Par Chembio Private Limited | ₹4.78 Cr (FY 2025) | 8.0% | Jaipur, Rajasthan, India | |||
| Vanprom Lifesciences Private Limited | ₹4.78 Cr (FY 2025) | 2.0% | New Delhi, Delhi, India | |||
| Biocare Organics Private Limited | ₹4.77 Cr (FY 2025) | 9.0% | Patna, Bihar, India | |||
| Radical Meditech Private Limitedthis company | ₹4.76 Cr (FY 2025) | ₹1.15 Lakh | 0.2% | 6.0% | Delhi, India | |
| Orlem Pharma Private Limited | ₹4.76 Cr (FY 2025) | -1.0% | Ernakulam, Kerala, India | |||
| SSR Medicare Private Limited | ₹4.76 Cr (FY 2025) | 100.0% | Delhi, India | |||
| Fertolife Sciences Private Limited | ₹4.74 Cr (FY 2025) | 4.0% | Nagpur, Maharashtra, India |
To see the full peer comparison of Radical Meditech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Radical Meditech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Radical Meditech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Radical Meditech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Radical Meditech Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Ankit Chhabra was appointed as Director on 19 Apr 2022.
Frequently asked questions
Radical Meditech is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 April 2022 (4+ years old) and is registered under CIN U51909DL2022PTC396858.
Radical Meditech has 2 current directors:
- Ratika Verma - Director
- Ankit Chhabra - Director
The latest financial statements of Radical Meditech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Radical Meditech is U51909DL2022PTC396858. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Radical Meditech was incorporated on 19 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Radical Meditech by revenue are Par Chembio Private Limited, Vanprom Lifesciences Private Limited, Biocare Organics Private Limited, Orlem Pharma Private Limited, SSR Medicare Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ankit Chhabra was appointed as Director on 19 Apr 2022. Ratika Verma was appointed as Director on 19 Apr 2022.
The registered office of Radical Meditech is at Mpl No – 1596 – Pvt No – 3 FF BS A C New Building Diwan Hall Chandni Chowk, Delhi, India – 110006.
Radical Meditech operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Radical Meditech can be reached at its registered office: Mpl No – 1596 – Pvt No – 3 FF BS A C New Building Diwan Hall Chandni Chowk, Delhi, India – 110006.
Radical Meditech is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.